Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Cooper C. Collins currently holds 52,016 shares of PERNIX THERAPEUTICS HOLDINGS, INC. (PTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cooper C. Collins has been a net seller of PTX stock. They have purchased $1.7M and sold $21.8M worth of shares.
Cooper C. Collins's most recent insider trade was on Aug 22, 2024, when they purchased 4,094 shares at $1.73 per share.
Cooper C. Collins serves as Executive at PERNIX THERAPEUTICS HOLDINGS, INC. (PTX). They have executed 46 insider transactions totaling $23.5M over their tenure at the company.
Cooper C. Collins holds the position of Executive at PERNIX THERAPEUTICS HOLDINGS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Cooper C. Collins has shown a selling trading pattern, with $1.7M in total purchases and $21.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Cooper C. Collins was on Mar 4, 2014, when they sold $11.9M worth of PTX shares. This transaction involved 3,500,000 shares at $3.40 per share.
Cooper C. Collins currently owns 52,016 shares of PERNIX THERAPEUTICS HOLDINGS, INC. (PTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Cooper C. Collins's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Cooper C. Collins has 46 Form 4 filings on record as an insider at PERNIX THERAPEUTICS HOLDINGS, INC..
Set alerts for Cooper C. Collins and 40,000+ other insiders.